• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Archives»Medical Devices & Diagnostics (Page 3)

OpenEvidence expands beyond search as Tandem partnership pushes medical AI into prescription access workflows

By Pallavi Madhiraju on April 4, 2026   Medical Devices & Diagnostics  

OpenEvidence expands beyond search as Tandem partnership pushes medical AI into prescription access workflows

OpenEvidence and Tandem are linking clinical AI with prior authorization automation. Read what this could change for prescribing, access, and workflow.

Can VR LIFE and H2 Global Group turn European MedTech validation into real global scale?

By Pallavi Madhiraju on April 4, 2026   Medical Devices & Diagnostics  

Can VR LIFE and H2 Global Group turn European MedTech validation into real global scale?

Can VR LIFE and H2 Global Group scale from European validation to global MedTech relevance? Read the deeper analysis now.

Can Allevion Medical’s Vantage change spinal stenosis workflows by combining disposable access, illumination, and bone resection tools?

By Pallavi Madhiraju on April 4, 2026   Medical Devices & Diagnostics  

Can Allevion Medical’s Vantage change spinal stenosis workflows by combining disposable access, illumination, and bone resection tools?

Allevion Medical’s Vantage won FDA 510(k) clearance for lumbar decompression. Read what this may change for spinal stenosis workflow, adoption, and risk.

Spacelabs Healthcare links Rothman Index to DEPTH Health as hospitals chase faster, safer bed movement

By Pallavi Madhiraju on April 4, 2026   Medical Devices & Diagnostics  

Spacelabs Healthcare links Rothman Index to DEPTH Health as hospitals chase faster, safer bed movement

Spacelabs Healthcare and DEPTH Health are pairing Rothman Index analytics with patient flow tools. Read what this could change for hospitals.

How ATL Medical’s PREVOYANCE imaging system could speed arthroscopy device development with OMNIVISION’s OH0131 processor

By Pallavi Madhiraju on April 4, 2026   Medical Devices & Diagnostics  

How ATL Medical’s PREVOYANCE imaging system could speed arthroscopy device development with OMNIVISION’s OH0131 processor

ATL Medical and OMNIVISION have expanded arthroscopy imaging integration. Read what this means for OEM speed, quality, and device development.

Can Peri turn perimenopause tracking into a credible new women’s health device category?

By Pallavi Madhiraju on April 3, 2026   Medical Devices & Diagnostics  

Can Peri turn perimenopause tracking into a credible new women’s health device category?

Peri has launched a perimenopause wearable, but can symptom tracking become clinical-grade insight? Read the deeper industry analysis now.

Why the Ro and Eli Lilly KwikPen move matters for obesity drug access, adherence, and pricing

By Pallavi Madhiraju on April 3, 2026   Medical Devices & Diagnostics  

Why the Ro and Eli Lilly KwikPen move matters for obesity drug access, adherence, and pricing

Ro launches Eli Lilly’s Zepbound KwikPen nationwide. Read what this means for GLP-1 access, pricing, adherence, and obesity care models.

Can Insight Health turn voice-first clinical agents into a durable healthcare infrastructure layer?

By Pallavi Madhiraju on April 3, 2026   Medical Devices & Diagnostics  

Can Insight Health turn voice-first clinical agents into a durable healthcare infrastructure layer?

Insight Health raised $11m to expand healthcare admin AI. Read what this funding means for scaling, adoption, and clinical workflow change.

Premier Radiology Services deepens outpatient teleradiology push with Global Imaging Solutions

By Pallavi Madhiraju on April 2, 2026   Medical Devices & Diagnostics  

Premier Radiology Services deepens outpatient teleradiology push with Global Imaging Solutions

Premier Radiology Services has acquired Global Imaging Solutions. Read what the teleradiology deal changes for outpatient imaging and market competition.

How electroCore, Inc. is strengthening the clinical case for bioelectronic medicine in trauma-related brain injury

By Soujanya Ravi on April 1, 2026   Medical Devices & Diagnostics  

How electroCore, Inc. is strengthening the clinical case for bioelectronic medicine in trauma-related brain injury

electroCore, Inc.’s latest data could reshape bioelectronic medicine in trauma-related brain injury. Read what clinicians and industry watchers may track next.

« Previous 1 2 3 4 5 … 29 Next »

Recent Posts

  • AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer
  • Agenus AACR 2026 data show immune reprogramming signal in PD-1 refractory gastroesophageal cancer
  • AACR 2026: Can Zai Lab’s zocilurtatug pelitecan change the treatment picture for small cell lung cancer brain metastases?
  • How JANX014 expands Janux Therapeutics’ tumor-activated platform strategy in prostate cancer immunotherapy
  • What Medicus Pharma Ltd.’s SkinJect application signals for Hedgehog pathway-driven cancers
  • Why Bioxodes’ adaptive trial strategy could accelerate approval timelines in stroke therapeutics
  • What Kura Oncology’s latest data reveals about resistance biology in kidney cancer
  • Can Fate Therapeutics, Inc. solve the conditioning chemotherapy problem in CAR T?
  • Could Ampligen become a late-stage pancreatic cancer breakthrough after AIM ImmunoTech’s latest clinical push?
  • What the new J-code means for Glaukos’ Epioxa launch and the future of keratoconus reimbursement
  • Molgramostim review pushed to November: what Savara’s FDA delay means for autoimmune PAP
  • What SurGenTec’s TiLink navigation clearance means for surgeons using minimally invasive SI joint fusion systems
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes